Five Prime Thera (FPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 379,801 | 19,231 | 13,791 | 9,983 | 64,916 |
| Gross Profit | 379,801 | 19,231 | 13,791 | 9,983 | 64,916 |
| Operating Expenses | 92,828 | 56,805 | 43,212 | 37,787 | 45,255 |
| Operating Income | 286,973 | -37,574 | -29,421 | -27,804 | 19,661 |
| Other Income | 484 | 150 | 549 | 209 | 49 |
| Pre-tax Income | 287,457 | -37,424 | -28,872 | -27,595 | 19,710 |
| Income Tax | 37,810 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 249,647 | -37,424 | -28,872 | -27,595 | 19,710 |
| Net Income | $249,647 | $-37,424 | $-28,872 | $-27,595 | $19,710 |
| EPS Basic Total Ops | 9.73 | -1.79 | -5.23 | -23.05 | 0.77 |
| EPS Basic Continuous Ops | 9.73 | -1.79 | -5.23 | -23.05 | 17.11 |
| EPS Diluted Total Ops | 9.23 | -1.79 | -5.23 | -23.05 | 0.72 |
| EPS Diluted Continuous Ops | 9.23 | -1.79 | -5.23 | -23.05 | 10.35 |
| EPS Diluted Before Non-Recurring Items | 9.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $290,676 | $-34,531 | $-27,295 | $-25,623 | $22,184 |